77302920 - BNO 1055

Information

• Trademark
• 77302920

• Source

• Serial Number

  77302920

• Registration Number

  3578606

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 3 - Bleaching preparations and other substances for laundry use
  • 5 - Pharmaceutical and veterinary preparations
  • 30 - Coffee, tea, cocoa and artificial coffee

• Filing Date

  October 12, 2007
  17 years ago

• Registration Date

  February 24, 2009
  16 years ago

• Transaction Date

  November 03, 2015
  9 years ago

• Status Date

  September 25, 2015
  9 years ago

• Published for Opposition Date

  December 09, 2008
  16 years ago

• Location Date

  April 28, 2009
  15 years ago

• Status Code

  710

• Current Location

  POST REGISTRATION

  Employee Name

  DIXON, JENNIFER HAZARD

• Attorney Docket Number

  1070-TM-152

  Attorney Name

  Kenneth F. Florek

  Law Office Assigned Location Code

  M10

• Owners

  • BIONORICA AG

Case File Statements

• B00001: In the statement, column 1, line 24. after the work teeth a comma ", " should be inserted, In column 2, line 4-5 after the word hypertension a comma " ," should be inserted, In column 2, line 40, after the word, hyperplasia, a comma "," should be inserted, and , In column 2, line 41, after the word muscular, a dash "-" should be inserted, and, on page 2, column 1, line 42, after the word tartar, a semi colon "; " should be inserted.
• GS0011: Vegetable extracts and tinctures in liquid, solid or gaseous form for manufacture of cosmetics, food and nutritional additives; plant extracts, namely, cimicifuga racemosa used in the manufacture of pharmaceutical preparations, bulk pharmaceutical preparations, and raw materials for pharmaceutical preparations
• GS0031: Essential oils for use in the manufacture of cosmetics; hair lotions; dentifrices
• GS0051: Pharmaceutical preparations for use in the treatment, cure, mitigation or prevention of gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities, neoplasia, breast neoplasm, breast cancer, mamma, mastopathy, mastodynia, premenstrual syndrome, climacteric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, vaginal discomfort due to menopausal atrophic changes, climactic sleep disturbances, depressive moods, osteoprotectio, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, neprholithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, arthritis, osteo arthritis, fever, cough, cold, Alzheimer's disease, infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, muscularskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressant, diuretic, hypnotic, sedative, stimulant, and tranquilizer; hemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; menstruation circulation regulating tablets; hormone preparations, hormone replacement medication; pharmaceutical preparations for sensory organs, namely, for use in ophthalmology, otolaryngology and dermatology; pharmaceutical preparations for regulation and strengthening of the immune system; pharmaceutical preparations for treating temporary relief of occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; pharmaceutical products, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of dental bleaching gels, gum balms, medicated dental floss, medicated dental tapes, medicated dental ribbons, medicated teeth whitener gels, medicated toothpicks, fluoride chewing gum and chewable tablets for disclosing dental plaque and tartar; preparations for dental purposes, namely, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria, caries, diagnostic reagents for detecting derivatives from caries-causal bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; medicated mouth sprays and desensitizers; plant extracts for veterinary and pharmaceutical purposes; sanitary preparations for medical use; sanitary preparations for hygiene, namely, antiseptics, oral antiseptics, disinfectants for hygiene purposes; sanitary preparations for the treatment, cleaning and protection of the skin; dietary supplements in the form of tablets, drops, capsules, extract preparations, balms or in liquid form, containing plant extracts; dietetic substances adapted for medical use in the form of tablets, drops, capsules, extract preparations, balms or in liquid form; food for medically restricted diets, food for diabetics, food supplements containing plant extracts, food supplements derived from plants or plant extracts, all aforesaid goods in the form of tablets, drops, capsules, extract preparations, balms or in liquid form; vitamin and mineral supplements; food supplements, namely, herbal teas for medicinal purposes and medicinal teas; nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; dietetic food supplements; dietary supplements; food supplements and dietary food supplements; mineral food supplements, food supplements based on amino acids, minerals and/or trace elements; food supplements; medical plasters; materials for dressings, namely, gauze and bandages; all purpose disinfectants; material for stopping teeth; dental wax
• GS0301: Plant extracts, tinctures and flavourings in liquid, solid or gaseous form or non-nutritional purposes in food used as flavorings and seasonings, herbal teas for food purposes; plant extracts used as flavouring in liquid, solid or gaseous form for foodstuffs, food supplements and food; foods and dietetic foods, namely, ready to eat cereal derived food bars; flavourings in liquid, solid or gaseous form for the manufacture of edible cosmetics and food; herbal teas

Case File Event Statements

• 9/25/2015 - 9 years ago

  30 - CANCELLED SEC. 8 (6-YR) Type: C8..

• 4/27/2010 - 14 years ago

  29 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 4/28/2009 - 15 years ago

  28 - CERTIFICATE OF CORRECTION ISSUED Type: COC.

• 4/23/2009 - 15 years ago

  27 - ASSIGNED TO PARALEGAL Type: PLGL

• 3/30/2009 - 16 years ago

  26 - SEC 7 REQUEST FILED Type: AMD7

• 3/30/2009 - 16 years ago

  25 - PAPER RECEIVED Type: MAIL

• 2/24/2009 - 16 years ago

  24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 12/9/2008 - 16 years ago

  23 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/25/2008 - 16 years ago

  22 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 11/25/2008 - 16 years ago

  21 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 11/19/2008 - 16 years ago

  20 - NOTICE OF PUBLICATION Type: NPUB

• 11/6/2008 - 16 years ago

  19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 10/2/2008 - 16 years ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/29/2008 - 16 years ago

  17 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 9/29/2008 - 16 years ago

  16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/29/2008 - 16 years ago

  15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 9/29/2008 - 16 years ago

  14 - PRIORITY ACTION MAILED Type: CPRA

• 9/29/2008 - 16 years ago

  13 - PRIORITY ACTION WRITTEN Type: CPRA

• 9/15/2008 - 16 years ago

  12 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 8/29/2008 - 16 years ago

  11 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 8/20/2008 - 16 years ago

  10 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 7/22/2008 - 16 years ago

  9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/4/2008 - 16 years ago

  8 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 6/4/2008 - 16 years ago

  7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/4/2008 - 16 years ago

  6 - ASSIGNED TO LIE Type: ALIE

• 6/2/2008 - 16 years ago

  5 - PAPER RECEIVED Type: MAIL

• 12/11/2007 - 17 years ago

  4 - NON-FINAL ACTION MAILED Type: CNRT

• 12/10/2007 - 17 years ago

  3 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/10/2007 - 17 years ago

  2 - ASSIGNED TO EXAMINER Type: DOCK

• 10/17/2007 - 17 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP